NanoViricides (NNVC) Competitors

Adagene (NASDAQ:ADAG) and NanoViricides (NYSE:NNVC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, community ranking, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

Is ADAG or NNVC more profitable?

Adagene's return on equity of 0.00% beat NanoViricides' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagene	N/A	N/A	N/A
NanoViricides	N/A	-87.90%	-78.69%

Does the MarketBeat Community favor ADAG or NNVC?

Adagene received 23 more outperform votes than NanoViricides when rated by MarketBeat users. Likewise, 79.31% of users gave Adagene an outperform vote while only 0.00% of users gave NanoViricides an outperform vote.

Company	Underperform	Outperform
Adagene	Outperform Votes 23 79.31%	Underperform Votes 6 20.69%
NanoViricides	Outperform Votes No Votes	Underperform Votes 57 100.00%

Do insiders & institutionals have more ownership in ADAG or NNVC?

9.5% of Adagene shares are owned by institutional investors. Comparatively, 10.3% of NanoViricides shares are owned by institutional investors. 21.2% of Adagene shares are owned by insiders. Comparatively, 4.6% of NanoViricides shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Which has better valuation and earnings, ADAG or NNVC?

NanoViricides has lower revenue, but higher earnings than Adagene.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagene	$103.20K	903.82	-$18.95M	N/A	N/A
NanoViricides	N/A	N/A	-$8.29M	-$0.70	-2.17

Does the media refer more to ADAG or NNVC?

In the previous week, Adagene and Adagene both had 1 articles in the media. Adagene's average media sentiment score of 1.87 beat NanoViricides' score of -1.00 indicating that Adagene is being referred to more favorably in the media.

Company	Overall Sentiment
Adagene	Very Positive
NanoViricides	Negative

Do analysts recommend ADAG or NNVC?

Adagene presently has a consensus price target of $8.00, suggesting a potential upside of 304.04%. Given Adagene's stronger consensus rating and higher possible upside, analysts clearly believe Adagene is more favorable than NanoViricides.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagene	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
NanoViricides	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has more volatility & risk, ADAG or NNVC?

Adagene has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500. Comparatively, NanoViricides has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500.

Summary

Adagene beats NanoViricides on 10 of the 13 factors compared between the two stocks.